Soegiharto, R. Et Al. 2024. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation. JAMA DERMATOLOGY .

Soegiharto, R., Aghdam, M. A., Sorensen, J. A., van Lindonk, E., Demir, F. B., Porras, N. M., ... Matsuo, Y.(2024). Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation. JAMA DERMATOLOGY .

Soegiharto, Reineke Et Al. "Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation," JAMA DERMATOLOGY , 2024

Soegiharto, Reineke Et Al. "Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation." JAMA DERMATOLOGY , 2024

Soegiharto, R. Et Al. (2024) . "Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation." JAMA DERMATOLOGY .

@article{article, author={Reineke Soegiharto Et Al. }, title={Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation}, journal={JAMA DERMATOLOGY}, year=2024}